A single dose of the modified vaccinia Ankara–Bavarian Nordic (MVA-BN) smallpox vaccine is 58% effective against mpox infection, according to a study in The BMJ. The results were based on 9800 men aged 18 years or older in Canada and come as mpox cases continue to spread in regions of Africa.
